Literature DB >> 8857678

Diabetes mellitus and morbidity and mortality risks after coronary artery bypass surgery.

O Risum1, M Abdelnoor, J L Svennevig, K Levorstad, L Gullestad, R Bjørnerheim, S Simonsen, S Nitter-Hauge.   

Abstract

Of 1025 patients (912 men, 113 women) who underwent coronary artery bypass grafting and were followed up for a mean of 7.4 years, 45 (4.4%) had diabetes mellitus. Norwegian population is 1.8-2%). Early mortality was not significantly greater among diabetics than in non-diabetics (2.2 vs. 3.1%, odds ratio--OR-0.44, confidence interval--CI- 0.05-3.56). Diabetic patients had no increased risk of perioperative myocardial infarction (OR = 0.87, CI 0.36-2.10) or of low-output syndrome necessitating intraortic balloon pumping (OR = 0.42, CI 0.55-3.05), and no excess incidence of late non-fatal myocardial infarction (relative risk = 0.69, CI 0.10-1.28) or late chronic heart failure (OR = 2.50, CI 0.5-11.0). Long-term mortality was increased in the diabetic patients (relative risk 1.87, CI 1.60-2.14). Thus diabetes did not entail heightened risk of early mortality, perioperative myocardial infarction or low-output syndrome. Nor was there excess risk of recurrent angina pectoris, late non-fatal myocardial infarction or chronic heart failure among the diabetic patients, but the late mortality risk was increased.

Entities:  

Mesh:

Year:  1996        PMID: 8857678     DOI: 10.3109/14017439609107245

Source DB:  PubMed          Journal:  Scand J Thorac Cardiovasc Surg        ISSN: 0036-5580


  9 in total

Review 1.  Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes.

Authors:  Ebenezer A Nyenwe; Terri W Jerkins; Guillermo E Umpierrez; Abbas E Kitabchi
Journal:  Metabolism       Date:  2011-01       Impact factor: 8.694

2.  The influence of general health status and social support on symptomatic outcome following coronary artery bypass grafting.

Authors:  G M Lindsay; L N Smith; P Hanlon; D J Wheatley
Journal:  Heart       Date:  2001-01       Impact factor: 5.994

3.  Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery.

Authors:  Anna Frisch; Prakash Chandra; Dawn Smiley; Limin Peng; Monica Rizzo; Chelsea Gatcliffe; Megan Hudson; Jose Mendoza; Rachel Johnson; Erica Lin; Guillermo E Umpierrez
Journal:  Diabetes Care       Date:  2010-04-30       Impact factor: 19.112

4.  Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery).

Authors:  Guillermo E Umpierrez; Dawn Smiley; Sol Jacobs; Limin Peng; Angel Temponi; Patrick Mulligan; Denise Umpierrez; Christopher Newton; Darin Olson; Monica Rizzo
Journal:  Diabetes Care       Date:  2011-01-12       Impact factor: 19.112

5.  The effect of diabetes mellitus on short term mortality and morbidity after isolated coronary artery bypass grafting surgery.

Authors:  Vahideh Koochemeshki; Hamid Reza Salmanzadeh; Hojjat Sayyadi; Morteza Amestejani; Shahyad Salehi Ardabili
Journal:  Int Cardiovasc Res J       Date:  2013-06-01

6.  Rationalization, Development, and Implementation of a Preoperative Diabetes Optimization Program Designed to Improve Perioperative Outcomes and Reduce Cost.

Authors:  Tracy Setji; Thomas J Hopkins; Maria Jimenez; Erin Manning; Michael Shaughnessy; Rebecca Schroeder; Sergio Mendoza-Lattes; Susan Spratt; Julie Westover; Solomon Aronson
Journal:  Diabetes Spectr       Date:  2017-08

Review 7.  Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.

Authors:  Jake Russell; Eugene F Du Toit; Jason N Peart; Hemal H Patel; John P Headrick
Journal:  Cardiovasc Diabetol       Date:  2017-12-04       Impact factor: 9.951

8.  Sitagliptin for prevention of stress hyperglycemia in patients without diabetes undergoing general surgery: A pilot randomized study.

Authors:  Maya Fayfman; Georgia Davis; Elizabeth W Duggan; Maria Urrutia; David Chachkhiani; Joanna Schindler; Francisco J Pasquel; Rodolfo J Galindo; Priyathama Vellanki; David Reyes-Umpierrez; Heqiong Wang; Guillermo E Umpierrez
Journal:  J Diabetes Complications       Date:  2018-09-01       Impact factor: 2.852

9.  Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery.

Authors:  Saumeth Cardona; Katerina Tsegka; Francisco J Pasquel; Maya Fayfman; Limin Peng; Sol Jacobs; Priyathama Vellanki; Michael Halkos; Robert A Guyton; Vinod H Thourani; Rodolfo J Galindo; Guillermo Umpierrez
Journal:  BMJ Open Diabetes Res Care       Date:  2019-09-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.